[go: up one dir, main page]

FR2889662B1 - Emulsion de type huile-dans-eau pour application topique en dermatologie - Google Patents

Emulsion de type huile-dans-eau pour application topique en dermatologie

Info

Publication number
FR2889662B1
FR2889662B1 FR0508524A FR0508524A FR2889662B1 FR 2889662 B1 FR2889662 B1 FR 2889662B1 FR 0508524 A FR0508524 A FR 0508524A FR 0508524 A FR0508524 A FR 0508524A FR 2889662 B1 FR2889662 B1 FR 2889662B1
Authority
FR
France
Prior art keywords
dermatology
oil
water emulsion
topical application
topical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0508524A
Other languages
English (en)
Other versions
FR2889662A1 (fr
Inventor
Orsoni Sandrine Segura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0508524A priority Critical patent/FR2889662B1/fr
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Priority to AU2006281346A priority patent/AU2006281346B2/en
Priority to RU2008108973/15A priority patent/RU2008108973A/ru
Priority to BRPI0616520-6A priority patent/BRPI0616520A2/pt
Priority to JP2008525600A priority patent/JP2009504619A/ja
Priority to CNA2006800374997A priority patent/CN101304729A/zh
Priority to CA002617963A priority patent/CA2617963A1/fr
Priority to PCT/FR2006/001930 priority patent/WO2007020349A1/fr
Priority to EP06794313A priority patent/EP1915133A1/fr
Priority to MX2008002012A priority patent/MX2008002012A/es
Priority to KR1020087003334A priority patent/KR20080033389A/ko
Publication of FR2889662A1 publication Critical patent/FR2889662A1/fr
Priority to US12/068,670 priority patent/US20080207570A1/en
Application granted granted Critical
Publication of FR2889662B1 publication Critical patent/FR2889662B1/fr
Priority to RU2011125550/15A priority patent/RU2011125550A/ru
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0508524A 2005-08-11 2005-08-11 Emulsion de type huile-dans-eau pour application topique en dermatologie Expired - Fee Related FR2889662B1 (fr)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FR0508524A FR2889662B1 (fr) 2005-08-11 2005-08-11 Emulsion de type huile-dans-eau pour application topique en dermatologie
KR1020087003334A KR20080033389A (ko) 2005-08-11 2006-08-09 피부과학에 있어서의 국소 적용용 수중유-형 에멀젼
BRPI0616520-6A BRPI0616520A2 (pt) 2005-08-11 2006-08-09 emulsão de tipo óleo-em-água, processo de preparação de uma emulsão e seu uso
JP2008525600A JP2009504619A (ja) 2005-08-11 2006-08-09 皮膚科学における局所適用用水中油型エマルション
CNA2006800374997A CN101304729A (zh) 2005-08-11 2006-08-09 皮肤病学中局部施用的水包油型乳液
CA002617963A CA2617963A1 (fr) 2005-08-11 2006-08-09 Emulsion de type huile-dans-eau pour application topique en dermatologie
AU2006281346A AU2006281346B2 (en) 2005-08-11 2006-08-09 Oil-in-water-type emulsion for topical application in dermatology
EP06794313A EP1915133A1 (fr) 2005-08-11 2006-08-09 Émulsion de type huile-dans-eau pour application topique en dermatologie
MX2008002012A MX2008002012A (es) 2005-08-11 2006-08-09 Emulsion de tipo aceite en agua para la aplicacion topica en dermatologia.
RU2008108973/15A RU2008108973A (ru) 2005-08-11 2006-08-09 Эмульсия типа масло-в-воде для топического нанесения в дерматологии
PCT/FR2006/001930 WO2007020349A1 (fr) 2005-08-11 2006-08-09 Émulsion de type huile-dans-eau pour application topique en dermatologie
US12/068,670 US20080207570A1 (en) 2005-08-11 2008-02-08 Topically applicable oil-in-water emulsions and dermatological applications thereof
RU2011125550/15A RU2011125550A (ru) 2005-08-11 2011-06-21 Эмульсия типа масло-в-воде для топического нанесения в дерматологии

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0508524A FR2889662B1 (fr) 2005-08-11 2005-08-11 Emulsion de type huile-dans-eau pour application topique en dermatologie

Publications (2)

Publication Number Publication Date
FR2889662A1 FR2889662A1 (fr) 2007-02-16
FR2889662B1 true FR2889662B1 (fr) 2011-01-14

Family

ID=36273334

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0508524A Expired - Fee Related FR2889662B1 (fr) 2005-08-11 2005-08-11 Emulsion de type huile-dans-eau pour application topique en dermatologie

Country Status (12)

Country Link
US (1) US20080207570A1 (fr)
EP (1) EP1915133A1 (fr)
JP (1) JP2009504619A (fr)
KR (1) KR20080033389A (fr)
CN (1) CN101304729A (fr)
AU (1) AU2006281346B2 (fr)
BR (1) BRPI0616520A2 (fr)
CA (1) CA2617963A1 (fr)
FR (1) FR2889662B1 (fr)
MX (1) MX2008002012A (fr)
RU (2) RU2008108973A (fr)
WO (1) WO2007020349A1 (fr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263580B2 (en) 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
WO2006129161A2 (fr) 2005-06-01 2006-12-07 Stiefel Research Australia Pty Ltd Preparation vitaminee
FR2892936A1 (fr) * 2005-11-10 2007-05-11 Galderma Res & Dev Composition pharmaceutique ou cosmetique, et procede de solubilisation mixte pour preparer la composition.
DK3184526T3 (en) 2005-12-13 2019-01-14 Incyte Holdings Corp PYRROLO [2,3-D] PYRIMIDINE DERIVATIVES AS A JANUS-KINASE INHIBITOR
FR2898499B1 (fr) * 2006-03-15 2008-11-28 Galderma Sa Nouvelles compositions topiques sous forme d'emulsion h/e comprenant un glycol pro-penetrant
FR2898498B1 (fr) * 2006-03-15 2008-11-28 Galderma Sa Nouvelles compositions topiques sous forme d'emulsion h/e comprenant un glycol pro-penetrant
US10265265B2 (en) * 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
FR2915682B1 (fr) * 2007-05-04 2009-07-03 Galderma Res & Dev Compositions depigmentantes dermatologiques et cosmetiques, leurs procedes de preparation, et leurs utilisations
DK2740731T3 (en) 2007-06-13 2016-04-11 Incyte Holdings Corp CRYSTALLINE SALTS OF JANUSKINASEINHIBITOREN (R) -3- (4- (7H-pyrrolo [2,3-d] pyrimidin-4-yl) -1H-pyrazol-1-yl) -3-CYCLOPENTYLPROPANNITRIL
EP2008651A1 (fr) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited Patch bioérodable
US20100249060A1 (en) * 2009-02-23 2010-09-30 Smith Jan G Topical formulation of low level clobetasol propionate for treating disorders of the skin and mucous membranes
WO2010115164A1 (fr) * 2009-04-03 2010-10-07 Medicis Pharmaceutical Corporation Compositions topiques
AU2010249443B2 (en) 2009-05-22 2015-08-13 Incyte Holdings Corporation 3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]octane- or heptane-nitrile as JAK inhibitors
MY156727A (en) 2009-05-22 2016-03-15 Incyte Corp N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
EP2473161B1 (fr) 2009-08-31 2017-05-17 Dr. Reddy's Laboratories Ltd. Compositions topiques contenant un stéroïde
TW201113285A (en) 2009-09-01 2011-04-16 Incyte Corp Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
US20110212035A1 (en) * 2010-02-26 2011-09-01 Collegium Pharmaceutical, Inc. Emollient foams for treatment of dermatoses
AU2011224484A1 (en) 2010-03-10 2012-09-27 Incyte Holdings Corporation Piperidin-4-yl azetidine derivatives as JAK1 inhibitors
MY161078A (en) * 2010-05-21 2017-04-14 Incyte Holdings Corp Topical formulation for a jak inhibitor
EP2640723A1 (fr) 2010-11-19 2013-09-25 Incyte Corporation Dérivés pyrrolopyridine et pyrrolopyrimidine à substitution cyclobutyle utilisés comme inhibiteurs des jak
WO2012123515A1 (fr) 2011-03-14 2012-09-20 Drug Delivery Solutions Limited Composition ophtalmique
KR20140040819A (ko) 2011-06-20 2014-04-03 인사이트 코포레이션 Ｊａｋ 저해제로서의 아제티디닐 페닐, 피리딜 또는 피라지닐 카르복스아미드 유도체
TW201313721A (zh) 2011-08-18 2013-04-01 Incyte Corp 作為ｊａｋ抑制劑之環己基氮雜環丁烷衍生物
UA111854C2 (uk) 2011-09-07 2016-06-24 Інсайт Холдінгс Корпорейшн Способи і проміжні сполуки для отримання інгібіторів jak
JP5909941B2 (ja) * 2011-09-08 2016-04-27 大正製薬株式会社 ステロイド性抗炎症薬含有外用剤
WO2013173720A1 (fr) 2012-05-18 2013-11-21 Incyte Corporation Dérivés de pyrrolopyridine et de pyrrolopyrimidine substitués par un pipéridinylcyclobutyle à titre d'inhibiteurs jak
PH12020551186B1 (en) 2012-11-15 2024-03-20 Incyte Holdings Corp Sustained-release dosage forms of ruxolitinib
JP6397831B2 (ja) 2013-03-06 2018-09-26 インサイト・ホールディングス・コーポレイションＩｎｃｙｔｅ Ｈｏｌｄｉｎｇｓ Ｃｏｒｐｏｒａｔｉｏｎ Ｊａｋ阻害剤の製造方法及びその中間体
MX2015013727A (es) * 2013-04-04 2016-02-29 Hyundai Pharm Co Ltd Composicion para preparacion de uso externo con permeabilidad transdermica mejorada.
JP2016520656A (ja) * 2013-06-03 2016-07-14 トルマー，インコーポレイティド コルチコステロイド組成物
KR20160045081A (ko) 2013-08-07 2016-04-26 인사이트 코포레이션 Jak1 억제제용 지속 방출 복용 형태
US20160184431A1 (en) * 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
WO2015184305A1 (fr) 2014-05-30 2015-12-03 Incyte Corporation Traitement de la leucémie neutrophile chronique (cnl) et de la leucémie myéloïde chronique atypique (acml) par des inhibiteurs de jak1
DE102014010875A1 (de) * 2014-07-25 2016-01-28 Basf Se Transparente Textilpflegemittel
WO2017037663A1 (fr) 2015-09-02 2017-03-09 Cadila Healthcare Limited Compositions topiques comprenant des corticostéroïdes
WO2017074982A1 (fr) 2015-10-30 2017-05-04 Patagonia Pharmaceuticals, Llc Formulations d'isotrétinoïne, leurs utilisations et méthodes associées
PH12019550291B1 (en) * 2017-06-23 2023-05-17 Salvat Lab Sa An oil-in-water nanoemulsion composition of clobetasol
WO2019113487A1 (fr) 2017-12-08 2019-06-13 Incyte Corporation Polythérapie à faible dose pour le traitement de néoplasmes myéloprolifératifs
CN112105608B (zh) 2018-01-30 2023-07-14 因赛特公司 制备(1-(3-氟-2-(三氟甲基)异烟碱基)哌啶-4-酮)的方法
EP3542788A1 (fr) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Composition topique comprenant calcipotriol et dipropionate de bétaméthasone
SMT202400306T1 (it) 2018-03-30 2024-09-16 Incyte Corp Trattamento dell'idrosadenite suppurativa utilizzando inibitori di jak.
CA3158619A1 (fr) * 2019-11-01 2021-05-06 Colgate-Palmolive Company Compositions de soins personnels stables a faible ph et leurs procedes d'utilisation
US11833155B2 (en) 2020-06-03 2023-12-05 Incyte Corporation Combination therapy for treatment of myeloproliferative neoplasms
CN113925800B (zh) * 2021-11-03 2024-09-13 时垠(上海)生物科技有限公司 提高单硬脂酸甘油酯乳化体系乳化能力的方法
KR102831554B1 (ko) * 2022-10-24 2025-07-09 주식회사 코리아나화장품 피부투과촉진 복합물을 포함하는 액정 겔 화장료 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837378A (en) * 1986-01-15 1989-06-06 Curatek Pharmaceuticals, Inc. Topical metronidazole formulations and therapeutic uses thereof
JP3454385B2 (ja) * 1993-10-15 2003-10-06 啓次郎 佐藤 Ｏ／ｗ型皮膚用クリームの製造方法
WO1998020852A1 (fr) * 1996-11-12 1998-05-22 Pharmacia & Upjohn Company Compositions pharmaceutiques contenant de l'huile de noix de kukui
US5972993A (en) * 1998-03-20 1999-10-26 Avon Products, Inc. Composition and method for treating rosacea and sensitive skin with free radical scavengers
FR2787025B1 (fr) * 1998-12-14 2002-10-11 Oreal Composition sous forme d'emulsion h/e a forte teneur en cire et ses utilisations dans les domaines cosmetique et dermatologique
US6403654B1 (en) * 2000-04-13 2002-06-11 Mariana De Oliveira Compositions for and method of treatment for psoriasis
US6699464B1 (en) * 2001-07-30 2004-03-02 Stiefel Laboratories, Inc. Compositions for treatment of hyperpigmentation and methods for making and using such compositions
WO2004080430A2 (fr) * 2003-03-13 2004-09-23 3M Innovative Properties Company Procedes pour ameliorer la qualite de la peau
FR2833841B1 (fr) * 2001-12-21 2005-07-22 Galderma Res & Dev Gel comprenant au moins un retinoide et du peroxyde de benzoyle
US20030129208A1 (en) * 2002-01-07 2003-07-10 Alberts David S. Topical application of alpha-DFMO and anti-inflammatory drug for treatment of actinic keratoses
AU2003252187A1 (en) * 2002-05-15 2003-12-02 Engelbrecht, Edna Topical composition for the treatment of inflammatory conditions of the skin
EP1796636B2 (fr) * 2004-08-31 2016-12-14 Stiefel Research Australia Pty Ltd Procede et compositions a base de microemulsion & emulsion submicronique

Also Published As

Publication number Publication date
EP1915133A1 (fr) 2008-04-30
US20080207570A1 (en) 2008-08-28
FR2889662A1 (fr) 2007-02-16
RU2011125550A (ru) 2012-12-27
WO2007020349A1 (fr) 2007-02-22
CA2617963A1 (fr) 2007-02-22
KR20080033389A (ko) 2008-04-16
BRPI0616520A2 (pt) 2011-06-21
CN101304729A (zh) 2008-11-12
MX2008002012A (es) 2008-03-25
RU2008108973A (ru) 2009-09-20
JP2009504619A (ja) 2009-02-05
AU2006281346A1 (en) 2007-02-22
AU2006281346B2 (en) 2012-03-29

Similar Documents

Publication Publication Date Title
FR2889662B1 (fr) Emulsion de type huile-dans-eau pour application topique en dermatologie
IL237632A (en) Liquid dispenser and method of use
EP1997270A4 (fr) Digipass pour la description fonctionnelle web
EP2127635A4 (fr) Composition d'émulsion de type huile-dans-eau
FR2875028B1 (fr) Mecanismes pour la virtualisation de cpu
DE502005009598D1 (de) Partikelstabilisierte emulsionen
EP1901702A4 (fr) Complexes ioniques
EP2050434A4 (fr) Agent hydratant
EP1806120A4 (fr) Composition pour prevenir ou diminuer la pigmentation
DE602006019342D1 (de) Einparkhilfe-Vorrichtung
DE602005008709D1 (de) Rollsteig
DE602005022364D1 (de) Selbstbräunendes kosmetikum
DE602005001478D1 (de) Oel-in-Wasser emulgierte Zusammensetzung
EP1805514A4 (fr) Immunodosages pour le topiramate
DE602006000877D1 (de) Emulsionszusammensetzung
EP1652523A4 (fr) Preparation pour absorption transdermique
FR2865545B1 (fr) Lidar compact
EP1847262A4 (fr) Produit cosmetique
DE602005003621D1 (de) Säure Öl-in-Wasser-Emulsionen
EP1956438A4 (fr) Révélateur liquide
DE502005005622D1 (de) Emulgatorkonzentrat für kosmetische zusammensetzung
FI20040870A0 (fi) Tela
DE502005005356D1 (de) Tripode-rolle
EP1915126A4 (fr) Nouvelle composition dermatologique
FR2905069B1 (fr) Dispersion cosmetique huile-dans-eau.

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse

Effective date: 20130430